What are the major opportunities in the Nasal Spray Influenza Vaccine market? What are the strategies for the Nasal Spray Influenza Vaccine market?

For detailed insights on the major opportunities and strategies in the Nasal Spray Influenza Vaccine market, Read More

How does the Nasal Spray Influenza Vaccine market relate to the overall economy and other similar markets?

For detailed insights on Nasal Spray Influenza Vaccine's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Nasal Spray Influenza Vaccine market growth? SWOT analysis of the Nasal Spray Influenza Vaccine market.

For detailed insights on the key dynamics influencing the Nasal Spray Influenza Vaccine market growth and SWOT analysis of the Nasal Spray Influenza Vaccine industry, Read More

Global Nasal Spray Influenza Vaccine Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Nasal Spray Influenza Vaccine Global Market Report 2025

Name: Nasal Spray Influenza Vaccine Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Type (Live Attenuated Influenza Vaccine (LAIV), Inactivated Influenza Vaccine), By Administration Method ( Single-Dose Administration, Multi-Dose Administration), By Age Group (Pediatric, Adult, Geriatric), By Distribution Channel (Hospitals, Clinics, Pharmacies, Online Stores, Other Distribution Channels), By End User (Healthcare Providers, Individuals, Government Health Departments, Pharmaceutical Companies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Nasal Spray Influenza Vaccine Market Overview

• Nasal Spray Influenza Vaccine market size has reached to $1.31 billion in 2024

• Expected to grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%

• Growth Driver: Increasing Prevalence Of Influenza Is Fueling The Market Growth Due To Rising Infection Rates And Virus Mutations

• Market Trend: The Role Of Live Attenuated Influenza Vaccines In Immune Response

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Nasal Spray Influenza Vaccine Market?

Nasal spray influenza vaccine refers to a needle-free flu vaccine administered through the nose that uses live attenuated viruses to protect against seasonal influenza. Nasal spray influenza vaccine is utilized by spraying it into the nostrils, where it stimulates an immune response in the nasal passages to protect against seasonal flu.

The main types of nasal spray influenza vaccines include the live attenuated influenza vaccine (LAIV) and the inactivated influenza vaccine. The live attenuated influenza vaccine (LAIV) is a needle-free flu vaccine that uses weakened live viruses to trigger strong systemic and mucosal immune responses. These vaccines are administered through various methods, such as single-dose and multi-dose administration. They are intended for different age groups, including pediatric, adult, and geriatric populations. Distribution channels include hospitals, clinics, pharmacies, online stores, and other outlets. The end users of nasal spray influenza vaccines include healthcare providers, individuals, government health departments, and pharmaceutical companies.

Nasal Spray Influenza Vaccine Market Size and growth rate 2025 to 2029: Graph

What Is The Nasal Spray Influenza Vaccine Market Size 2025 And Growth Rate?

What Is The Nasal Spray Influenza Vaccine Market Growth Forecast?

The nasal spray influenza vaccine market size is expected to see rapid growth in the next few years. It will grow to $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to rising demand for convenient immunization, growing incidences of seasonal influenza, increasing government initiatives and support, forecasted growth in geriatric and high-risk populations, and increasing adoption in healthcare settings. Major trends in the forecast period include advancements in vaccine delivery systems, integration of mucosal immunity strategies, technology developments in viral vector platforms, advancements in cold-chain technology, and integration of mRNA technology.

The forecast of 12.7% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could disrupt U.S. vaccination programs by inflating prices of live-attenuated vaccine strains and nasal applicator devices developed in the UK and Netherlands, potentially slowing seasonal immunization efforts and raising public health campaign costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Nasal Spray Influenza Vaccine Market Segmented?

1) By Type: Live Attenuated Influenza Vaccine (LAIV), Inactivated Influenza Vaccine

2) By Administration Method: Single-Dose Administration, Multi-Dose Administration

3) By Age Group: Pediatric, Adult, Geriatric

4) By Distribution Channel: Hospitals, Clinics, Pharmacies, Online Stores, Other Distribution Channels

5) By End User: Healthcare Providers, Individuals, Government Health Departments, Pharmaceutical Companies

Subsegments:

1) By Live Attenuated Influenza Vaccine (LAIV): Trivalent Live Attenuated Influenza Vaccine (Trivalent LAIV), Quadrivalent Live Attenuated Influenza Vaccine (Quadrivalent LAIV)

2) By Inactivated Influenza Vaccine: Whole Virus Inactivated Vaccine, Split Virus Inactivated Vaccine, Subunit Inactivated Vaccine, Adjuvanted Inactivated Vaccine, High-Dose Inactivated Vaccine

What Is Driving The Nasal Spray Influenza Vaccine Market? Increasing Prevalence Of Influenza Is Fueling The Market Growth Due To Rising Infection Rates And Virus Mutations

The increasing prevalence of influenza is expected to propel the growth of nasal spray influenza vaccine going forward. Influenza refers to a highly contagious viral infection that primarily affects the respiratory system, causing symptoms such as fever, cough, sore throat, body aches, and fatigue. The increasing prevalence of influenza is primarily due to the frequent genetic mutations of the influenza virus, which enable it to evade existing immunity and spread rapidly among populations. Nasal spray influenza vaccine helps protect against influenza by delivering a weakened form of the virus directly into the nasal passages, stimulating an immune response where the virus typically enters the body. For instance, in June 2024, according to the UK Health Security Agency, a UK-based government agency, between week 40 of 2022 and week 15 of 2023, 1,681 confirmed influenza-related critical care admissions were reported by 108 NHS trusts in England. In comparison, the previous season saw only 182 admissions reported by 114 trusts, increasing to 316 admissions by week 39 of 2022. Therefore, the increasing prevalence of influenza is driving the growth of the nasal spray influenza vaccine industry.

Who Are The Major Players In The Global Nasal Spray Influenza Vaccine Market?

Major companies operating in the nasal spray influenza vaccine market are Sanofi Pasteur SA, AstraZeneca PLC, GSK plc, Moderna Inc., CSL Limited, Sinovac Biotech Ltd., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., NPO Microgen JSC, Changchun BCHT Biotechnology Co. Ltd., Mitsubishi Tanabe Pharma Corporation, FluGen Inc., BioDiem Ltd, Starpharma Holdings Limited, Codagenix Inc., Nobilon International B.V., KM Biologics Co. Ltd., Altimmune Inc., Mylab Discovery Solutions Private Limited

What Are The Key Trends Of The Global Nasal Spray Influenza Vaccine Market? The Role Of Live Attenuated Influenza Vaccines In Immune Response

Major companies operating in the nasal spray influenza vaccine market are focusing on developing innovative formulations such as live attenuated influenza vaccine to enhance immune response and improve patient compliance. A live attenuated influenza vaccine (LAIV) is a flu vaccine made from live, weakened influenza viruses that helps prevent influenza by stimulating the immune system to produce antibodies, providing protection without causing the disease, and offering a more comprehensive immune response through both local and systemic immunity, which enhances the body's ability to defend against future flu infections. For instance, in September 2024, AstraZeneca Plc, a UK-based pharmaceutical industry company, received approval from the U.S. Food and Drug Administration (FDA) for FluMist, a live attenuated influenza vaccine (LAIV), to be self-administered by adults aged up to 49 years or administered by caregivers to children aged 2 to 17 years, making it the first and only influenza vaccine approved for self- or caregiver-administration in the United States. This approval was based on comprehensive usability studies that demonstrated the ability of individuals to correctly self-administer the vaccine, with 100% of participants delivering a full dose as instructed.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Nasal Spray Influenza Vaccine Market? Mylab Discovery Solutions Partners With Serum Institute Of India To Launch Nasovac S4

In October 2023, Mylab Discovery Solutions Private Limited, an India-based biotechnology company, partnered with Serum Institute of India Private Limited to launch Nasovac S4, India's first nasal influenza vaccine. With this partnership, Mylab Discovery Solutions Private Limited and Serum Institute of India Private Limited aim to offer comprehensive protection against a wide range of influenza strains through the introduction of Nasovac S4, India's first needle-free nasal influenza vaccine. Serum Institute of India Private Limited is an India-based biotechnology company that specializes in providing Nasovac-S and Nasovac-S4 nasal influenza vaccines.

What Is The Regional Outlook For The Global Nasal Spray Influenza Vaccine Market?

North America was the largest region in the nasal spray influenza vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Nasal Spray Influenza Vaccine Market?

The nasal spray influenza vaccine market consists of sales of flumist quadrivalent, fluenz tetra, vaxinate, centripetal flu nasal spray vaccine, nasovac-s, fluvac nasal spray, and live attenuated influenza vaccine. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Nasal Spray Influenza Vaccine Industry?

The nasal spray influenza vaccine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the nasal spray influenza vaccine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Nasal Spray Influenza Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.48 billion
Revenue Forecast In 2034	$2.38 billion
Growth Rate	CAGR of 12.7% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The nasal spray influenza vaccine market covered in this report is segmented – 1) By Type: Live Attenuated Influenza Vaccine (LAIV), Inactivated Influenza Vaccine 2) By Administration Method: Single-Dose Administration, Multi-Dose Administration 3) By Age Group: Pediatric, Adult, Geriatric 4) By Distribution Channel: Hospitals, Clinics, Pharmacies, Online Stores, Other Distribution Channels 5) By End User: Healthcare Providers, Individuals, Government Health Departments, Pharmaceutical Companies Subsegments: 1) By Live Attenuated Influenza Vaccine (LAIV): Trivalent Live Attenuated Influenza Vaccine (Trivalent LAIV), Quadrivalent Live Attenuated Influenza Vaccine (Quadrivalent LAIV) 2) By Inactivated Influenza Vaccine: Whole Virus Inactivated Vaccine, Split Virus Inactivated Vaccine, Subunit Inactivated Vaccine, Adjuvanted Inactivated Vaccine, High-Dose Inactivated Vaccine
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi Pasteur SA, AstraZeneca PLC, GSK plc, Moderna Inc., CSL Limited, Sinovac Biotech Ltd., Emergent BioSolutions Inc., Serum Institute of India Pvt. Ltd., Beijing Wantai Biological Pharmacy Enterprise Co. Ltd., NPO Microgen JSC, Changchun BCHT Biotechnology Co. Ltd., Mitsubishi Tanabe Pharma Corporation, FluGen Inc., BioDiem Ltd, Starpharma Holdings Limited, Codagenix Inc., Nobilon International B.V., KM Biologics Co. Ltd., Altimmune Inc., Mylab Discovery Solutions Private Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Nasal Spray Influenza Vaccine Market Characteristics

3. Nasal Spray Influenza Vaccine Market Trends And Strategies

4. Nasal Spray Influenza Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Nasal Spray Influenza Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Nasal Spray Influenza Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Nasal Spray Influenza Vaccine Market Growth Rate Analysis

5.4. Global Nasal Spray Influenza Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Nasal Spray Influenza Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Nasal Spray Influenza Vaccine Total Addressable Market (TAM)

6. Nasal Spray Influenza Vaccine Market Segmentation

6.1. Global Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Live Attenuated Influenza Vaccine (LAIV)

Inactivated Influenza Vaccine

6.2. Global Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Single-Dose Administration

Multi-Dose Administration

6.3. Global Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric

Adult

Geriatric

6.4. Global Nasal Spray Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Pharmacies

Online Stores

Other Distribution Channels

6.5. Global Nasal Spray Influenza Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Healthcare Providers

Individuals

Government Health Departments

Pharmaceutical Companies

6.6. Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Live Attenuated Influenza Vaccine (LAIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Trivalent Live Attenuated Influenza Vaccine (Trivalent LAIV)

Quadrivalent Live Attenuated Influenza Vaccine (Quadrivalent LAIV)

6.7. Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Inactivated Influenza Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Whole Virus Inactivated Vaccine

Split Virus Inactivated Vaccine

Subunit Inactivated Vaccine

Adjuvanted Inactivated Vaccine

High-Dose Inactivated Vaccine

7. Nasal Spray Influenza Vaccine Market Regional And Country Analysis

7.1. Global Nasal Spray Influenza Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Nasal Spray Influenza Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nasal Spray Influenza Vaccine Market

8.1. Asia-Pacific Nasal Spray Influenza Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nasal Spray Influenza Vaccine Market

9.1. China Nasal Spray Influenza Vaccine Market Overview

9.2. China Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nasal Spray Influenza Vaccine Market

10.1. India Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nasal Spray Influenza Vaccine Market

11.1. Japan Nasal Spray Influenza Vaccine Market Overview

11.2. Japan Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nasal Spray Influenza Vaccine Market

12.1. Australia Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nasal Spray Influenza Vaccine Market

13.1. Indonesia Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nasal Spray Influenza Vaccine Market

14.1. South Korea Nasal Spray Influenza Vaccine Market Overview

14.2. South Korea Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nasal Spray Influenza Vaccine Market

15.1. Western Europe Nasal Spray Influenza Vaccine Market Overview

15.2. Western Europe Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nasal Spray Influenza Vaccine Market

16.1. UK Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nasal Spray Influenza Vaccine Market

17.1. Germany Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nasal Spray Influenza Vaccine Market

18.1. France Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nasal Spray Influenza Vaccine Market

19.1. Italy Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nasal Spray Influenza Vaccine Market

20.1. Spain Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nasal Spray Influenza Vaccine Market

21.1. Eastern Europe Nasal Spray Influenza Vaccine Market Overview

21.2. Eastern Europe Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nasal Spray Influenza Vaccine Market

22.1. Russia Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nasal Spray Influenza Vaccine Market

23.1. North America Nasal Spray Influenza Vaccine Market Overview

23.2. North America Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nasal Spray Influenza Vaccine Market

24.1. USA Nasal Spray Influenza Vaccine Market Overview

24.2. USA Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nasal Spray Influenza Vaccine Market

25.1. Canada Nasal Spray Influenza Vaccine Market Overview

25.2. Canada Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nasal Spray Influenza Vaccine Market

26.1. South America Nasal Spray Influenza Vaccine Market Overview

26.2. South America Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nasal Spray Influenza Vaccine Market

27.1. Brazil Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nasal Spray Influenza Vaccine Market

28.1. Middle East Nasal Spray Influenza Vaccine Market Overview

28.2. Middle East Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nasal Spray Influenza Vaccine Market

29.1. Africa Nasal Spray Influenza Vaccine Market Overview

29.2. Africa Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nasal Spray Influenza Vaccine Market Competitive Landscape And Company Profiles

30.1. Nasal Spray Influenza Vaccine Market Competitive Landscape

30.2. Nasal Spray Influenza Vaccine Market Company Profiles

30.2.1. Sanofi Pasteur SA Overview, Products and Services, Strategy and Financial Analysis

30.2.2. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. GSK plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Moderna Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. CSL Limited Overview, Products and Services, Strategy and Financial Analysis

31. Nasal Spray Influenza Vaccine Market Other Major And Innovative Companies

31.1. Sinovac Biotech Ltd.

31.2. Emergent BioSolutions Inc.

31.3. Serum Institute of India Pvt. Ltd.

31.4. Beijing Wantai Biological Pharmacy Enterprise Co. Ltd.

31.5. NPO Microgen JSC

31.6. Changchun BCHT Biotechnology Co. Ltd.

31.7. Mitsubishi Tanabe Pharma Corporation

31.8. FluGen Inc.

31.9. BioDiem Ltd

31.10. Starpharma Holdings Limited

31.11. Codagenix Inc.

31.12. Nobilon International B.V.

31.13. KM Biologics Co. Ltd.

31.14. Altimmune Inc.

31.15. Mylab Discovery Solutions Private Limited

32. Global Nasal Spray Influenza Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nasal Spray Influenza Vaccine Market

34. Recent Developments In The Nasal Spray Influenza Vaccine Market

35. Nasal Spray Influenza Vaccine Market High Potential Countries, Segments and Strategies

35.1 Nasal Spray Influenza Vaccine Market In 2029 - Countries Offering Most New Opportunities

35.2 Nasal Spray Influenza Vaccine Market In 2029 - Segments Offering Most New Opportunities

35.3 Nasal Spray Influenza Vaccine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Nasal Spray Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Nasal Spray Influenza Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Live Attenuated Influenza Vaccine (LAIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Inactivated Influenza Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Nasal Spray Influenza Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Nasal Spray Influenza Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Sanofi Pasteur SA Financial Performance

Table 79: AstraZeneca PLC Financial Performance

Table 80: GSK plc Financial Performance

Table 81: Moderna Inc. Financial Performance

Table 82: CSL Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Nasal Spray Influenza Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Nasal Spray Influenza Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Live Attenuated Influenza Vaccine (LAIV), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Nasal Spray Influenza Vaccine Market, Sub-Segmentation Of Inactivated Influenza Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Nasal Spray Influenza Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Nasal Spray Influenza Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Administration Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Nasal Spray Influenza Vaccine Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Sanofi Pasteur SA Financial Performance

Figure 79: AstraZeneca PLC Financial Performance

Figure 80: GSK plc Financial Performance

Figure 81: Moderna Inc. Financial Performance

Figure 82: CSL Limited Financial Performance

Next-Gen Primary Health Care Service : Market Forecast, Transformation, and Long-Term Trajectories

Progressive Ataxia And Weakness Disorders Growth Trajectory: Key Forecasts and Strategic Insights

Prostate Cancer Nuclear Medicine Diagnostics Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prostate Cancer Nuclear Medicine Diagnostics Market Landscape: Automated Parallel Capillary Electrophoresis Systems Transforming Protein Analysis In The Protein Chip Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Explore the latest trends, growth insights, and forecasts in the Nutrition Analysis Software Global Market.

Nasal Spray Bottle Global Market Report 2025 – By Product Type (Saline Nasal Spray, Decongestion Nasal Spray, Steroid Nasal Spray, Antihistamine Nasal Spray), By Container Design (Pump Bottles, Pressurized Canisters), By...

Anthrax Vaccine Global Market Report 2025 – By Vaccine Type (Cell-Free Protective Antigen (PA) Vaccine, Live Attenuated Vaccine), By Application Type (Animal Use, Human Use), By Distribution Channel (Hospitals, Pharmacie...

Influenza Vaccines Global Market Report 2025 – By Vaccine Type (Inactivated, Live Attenuated), By Valency (Quadrivalent, Trivalent), By Route Of Administration (Injection, Nasal Spray), By Age Group (Pediatric, Adult), B...

Influenza Treatment Global Market Report 2025 – By Product Type (Peramivir, Zanamivir, Oseltamivir Phosphate, Baloxavir Marboxil, Other Products), By Route Of Administration (Oral, Other Routes Of Administration), By Dis...

Respiratory Disease Vaccine Global Market Report 2025 – By Type (Viral Vaccine, Bacterial Vaccine, Combination Vaccine), By Infection (COVID-19, Influenza, Respiratory Syncytial Virus (RSV), Pneumonia, Other Infections),...

Influenza Diagnostic Global Market Report 2025 – By Traditional diagnostic tests (Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests), By Molecular diagnos...

Swine Flu Vaccination Global Market Report 2025 – By Vaccine Type (Intranasal, Toxoid, Conjugate, Inactivated Vaccine, Attenuated Vaccine, Other Vaccine Type), By Treatment Type (Influenza, Meningococcal, Cervical Cancer...

Frequently Asked Questions

What is the definition of the Nasal Spray Influenza Vaccine market?

How will the Nasal Spray Influenza Vaccine market drivers and restraints affect the market dynamics? What forces will shape the Nasal Spray Influenza Vaccine industry going forward?

The market major growth driver - Increasing Prevalence Of Influenza Is Fueling The Market Growth Due To Rising Infection Rates And Virus Mutations. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Nasal Spray Influenza Vaccine market?

The nasal spray influenza vaccine market size has grown rapidly in recent years. It will grow from $1.31 billion in 2024 to $1.48 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to increasing vaccine accessibility, rising awareness of flu prevention, growing focus on pediatric vaccination, rising vaccination rates, and increasing preferences for needle-free vaccines. The nasal spray influenza vaccine market size is expected to see rapid growth in the next few years. It will grow to " $2.38 billion in 2029 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to rising demand for convenient immunization, growing incidences of seasonal influenza, increasing government initiatives and support, forecasted growth in geriatric and high-risk populations, and increasing adoption in healthcare settings. Major trends in the forecast period include advancements in vaccine delivery systems, integration of mucosal immunity strategies, technology developments in viral vector platforms, advancements in cold-chain technology, and integration of mRNA technology. For further insights on this market, request a sample here

How is the Nasal Spray Influenza Vaccine market segmented?

The nasal spray influenza vaccinemarket covered in this report is segmented –
1) By Type: Live Attenuated Influenza Vaccine (LAIV); Inactivated Influenza Vaccine
2) By Administration Method: Single-Dose Administration; Multi-Dose Administration
3) By Age Group: Pediatric; Adult; Geriatric
4) By Distribution Channel: Hospitals; Clinics; Pharmacies; Online Stores; Other Distribution Channels
5) By End User: Healthcare Providers; Individuals; Government Health Departments; Pharmaceutical Companies Subsegments:
1) By Live Attenuated Influenza Vaccine (LAIV): Trivalent Live Attenuated Influenza Vaccine (Trivalent LAIV); Quadrivalent Live Attenuated Influenza Vaccine (Quadrivalent LAIV)
2) By Inactivated Influenza Vaccine: Whole Virus Inactivated Vaccine; Split Virus Inactivated Vaccine; Subunit Inactivated Vaccine; Adjuvanted Inactivated Vaccine; High-Dose Inactivated Vaccine For further insights on this market, request a sample here

Which region has the largest share of the Nasal Spray Influenza Vaccine market? What are the other regions covered in the report?

North America was the largest region in the nasal spray influenza vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nasal spray influenza vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Nasal Spray Influenza Vaccine market?

What are the key trends in the Nasal Spray Influenza Vaccine market?

Major trends in this market include The Role Of Live Attenuated Influenza Vaccines In Immune Response. For further insights on this market, request a sample here.